Saturday, September 28, 2024
HomeTagsCovid-19

Covid-19

Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 Vaccine

While one in four blood cancer patients do not produce detectable antibodies after their first two doses of the COVID-19 vaccine, 43% of them...

Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant

Brii Biosciences Limited , a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new...

Nobel Prize laureates looked into the future of technologies at Nobel Vision

Laureates of the Nobel, Wolf, Abel Prizes and the Fields Medal, leading Russian and foreign scientists, futurologists, participants of Thinkers50 rating, representatives of the...

GenScript ProBio Opens China’s Largest Commercial GMP Plasmid Manufacturing Facility

GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province....

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

Roche Announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics